Are ICD-10 Codes for Fluoroquinolone Adverse Events on the Horizon?
Are ICD-10 codes on the horizon for Fluoroquinolone Toxicity?
Are ICD-10 codes on the horizon for Fluoroquinolone Toxicity?
Scientists have been tinkering with the fluoroquinolone family of antibiotics to try and find a herbicide replacement for glyphosate.
History is replete with lessons that caution against resorting to haste in times of desperation because during these times well-meaning cures can become the cure that kills instead.
One pill or one thousand thousand, for each person the threshold is different. But make no bones about it, there is a threshold for each person. A line, that once it is crossed, there is no going back.
Pharmaceutical research since 2009 as shown that quinolone molecules are suitable for designing newer derivatives against influenza viruses based upon promising antiviral activity seen.
Recently I did an interview with WebMD author/reporter Matt McMillen on the dangers of Fluoroquinolones.
Pharmaceutical companies hide, ignore, or misrepresent evidence about new drugs; distort the medical literature; and misrepresent products to prescribing physicians.
Drug’s that can mutate DNA and create a disease process are downright scary. They start the ball rolling on a pathology that often appears later on..
So the next time someone asks you ‘Why are these drugs still on the market?” even though you may not agree, you will at least know the answer.
Thank you for watching this video. The following is a list of links to materials documenting the data presented in this video.
Fluoroquinolones damage mammalian mitochondrial DNA via Topoisomerase II:
http://molpharm.aspetjournals.org/content/50/5/1178.long
This article states “These results suggest that ciprofloxacin may be causing cytotoxicity by interfering with a mitochondrial topoisomerase II”
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760005/
This article states “quinolones target bacterial gyrases (34) and mtDNA topoisomerases (15),”
Quinolones and damage mammalian mitochondrial DNA:
FDA’s April 27, 2013 Pharmacovigilance Review, where the FDA notes that the mechanism for action through which fluoroquinolones induce peripheral neuropathy is mitochondrial toxicity.
Fluoroquinolones as adjunct to chemotherapy:
http://infectagentscancer.biomedcentral.com/articles/10.1186/1750-9378-7-33
http://www.nature.com/bjc/journal/v95/n8/full/6603355a.html
https://www.ncbi.nlm.nih.gov/pubmed/10414727
Fluoroquinolone based chemotherapy agents:
https://pubmed.ncbi.nlm.nih.gov/28504025/
Antitumor Power of The Quinolone Antibiotics
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997924/
Article states “quinolones having significant potency against eukaryotic Type II topoisomerases (topo II)”
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745469
Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities
Fluoroquinolones described as chemotherapy
http://pharmaxchange.info/press/2011/05/mechanism-of-action-of-quinolones-and-fluoroquinolones/
“Late Effects” of chemotherapy
http://www.cancer.net/survivorship/long-term-side-effects-cancer-treatment
http://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer-survivor/art-20045524
http://ww5.komen.org/BreastCancer/LongTermSideEffectsofChemotherapy.html
Every once in a while I get the dubious honor of talking to a doctor who has been floxed. This conversation was a poignant example of dangerous the FQ’s are in our society